C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/30 (2006.01) A61K 31/505 (2006.01)
Patent
CA 2590250
Described herein are compounds that are useful as protein kinase inhibitors of formula (I); or a pharmaceutically acceptable salt thereof, wherein Ring A, Z1, Z2, U, Q, R1, R2, and L are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.
L'invention concerne des composés utilisés comme inhibiteurs de la protéine kinase, qui sont représentés par la formule (I); ou un sel pharmaceutiquement acceptable de ceux-ci. Dans cette formule, les cycles A, Z1, Z2, U, Q, R1, R2, et L sont tels que décrits dans le descriptif. Ces composés, ainsi que les compositions pharmaceutiquement acceptables de ceux-ci, sont utilisés pour traiter ou diminuer la gravité d'une variété de troubles, y compris les troubles prolifératifs tels que le cancer.
Aronov Alex
Hale Michael R.
Maltais Francois
Martinez-Botella Gabriel
Straub Judith
Smart & Biggar
Vertex Pharmaceuticals Incorporated
LandOfFree
Pyrimidine inhibitors of erk protein kinase and uses therof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine inhibitors of erk protein kinase and uses therof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine inhibitors of erk protein kinase and uses therof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1685220